TRILUMINATE Pivotal Trial: Outcomes in the Primary Analysis Population vs Subsequent Enrollment
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Medtronic; Boston Scientific Corporation; Siemens Healthineers; Shockwave Medical; Peija Medical; Shenqi Medical Technology
- Advisory board member - JenaValve
- Anatomic eligibility committee member of TRILUMINATE trials and Publications Committee - Abbott
- Screening Committee member of the APOLLO trial, steering committee member of the IMPACT-MR trial, TAVR Publications Committee member - Medtronic